載入...
A RARE CAUSE OF PITUITARY APOPLEXY: CABERGOLINE THERAPY
Pituitary apoplexy (PA) is a life-threatening clinical syndrome. Dopamine receptor agonists are the drugs of choice in the treatment of prolactinomas. The use of cabergoline is reported to cause an increased risk of PA, particularly in macroprolactinomas of cystic nature. In this report, we present...
Na minha lista:
| 發表在: | Acta Endocrinol (Buchar) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Acta Endocrinologica Foundation
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516607/ https://ncbi.nlm.nih.gov/pubmed/31149244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2018.113 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|